male and female, were challenged with gliadin for one or two days, to evaluate the effects of gliadin on TER, permability and CFTR function.
The mice were challenged via gavage for with i) vehicle alone or ii) gliadin (Sigma-Aldich, G3375) (daily somministration, 20 mg/mice in 100ul saline) (Moon et al, 2016 ) (n=10 mice per group of treatment).
At the end of the last daily treatment, mice were anesthetized with Avertine (tribromoethanol, 250 mg/kg, Sigma Aldrich, T48402) and then killed; the intestines were collected for CFTR function analysis or stored for all described techniques.
These studies and procedures were approved by the local Ethics Committee for Animal Welfare (IACUC No 583, 849) and conformed to the European Community regulations for animal use in research (2010/63 UE).
Halide efflux analysis
The analysis of halide efflux was performed by the iodide-sensitive fluorescent indicator, SPQ (Molecular Probes/Invitrogen), as previously described (Villella et al, 2013; Luciani et al, 2010b; Maiuri et al, 2008; Luciani et al, 2009; Luciani et al, 2010a) . The peak of halide efflux rate (usually after Fsk plus IBMX adding) of cells was calculated in accordance with the Stern-Volmer relationship. The rates were calculated using SigmaPlot Version 7.1 for each mean fluorescence trace for each time point generated from the 50 cells examined per population per coverslip.
Briefly, 1 ug of pcDNA-CFTR-wilde type plasmide was incubated with mixed reagents of TnT® Coupled Reticulocyte Lysate Systems kit (Promega, L4611). To ensure the glycosilation of full lenght CFTR, the system was added with Canine Microsomal
Membranes
The reaction was performed as described: 
Limited proteolysis of CFTR.
Membran fraction (1-1.5 mg\ml protein) were digested in PBS buffer at the indicated concentration of trypsin for 15 min on ice as described ( Okiyoneda et al, 2010; Du et Cftr F508del/F508del Cftr WT 50µm 10µm 10µm Figure S1 . (B) BALB/c mice fed for at least 3 generations with a gluten-free diet and orally challenged with vehicle or gliadin (20 mg/mice in 100ul saline/day) for one or two days (n=10 mice per group of treatment). IFNγ production (by ELISA assay) in whole lysates from small intestine homogenates.
Mean ± SD of of triplicates of independent pooled samples. 
